average weight loss on compounded tirzepatide Monthly Mounjaro Compound Tirzepatide For Weight Loss

The medication is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, and is not indicated for type 1 diabetes or use with other GLP-1 receptor agonists

These side effects are much rarer and include: Pancreatitis Sudden kidney injury Worsening diabetes-related retinopathy

It has been available as a generic for decades, and cost is rarely a barrier to access

Over time, it may slow down cognitive decline and boost heart health

Vitamin B12 GLP-1 agonists can sometimes interfere with the absorption of vitamin B-12 in the gastrointestinal tract, potentially leading to lower levels of this essential nutrient over time

The goal should always be losing fat while preserving lean muscle